# Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia

> **NCT00100971** · PHASE1 · TERMINATED · sponsor: **Boston Medical Center** · enrollment: 9 (—)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** autologous tumor cell vaccine
- **DRUG:** therapeutic autologous dendritic cells
- **PROCEDURE:** tumor cell-derivative vaccine therapy

## Key facts

- **NCT ID:** NCT00100971
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-04
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 9 (—)
- **Why stopped:** Protocol is withdrawn due to inadequate accrual
- **Last updated:** 2013-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100971, "Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00100971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*